CClinicalTrials.gg
Not yet recruitingNCT07199101Updated Sep 30, 2025

Multicenter Pediatric Low-Dose CT Protocol: Development and Clinical Verification

An interventional study of Low dose CT in Radiation Dose Reduction, sponsored by Beijing Children's Hospital. Not yet recruiting at 20 sites in China. Open to participants aged 0 Years to 18 Years. Per ClinicalTrials.gov, last updated 2025-09-30.

Sponsored by Beijing Children's Hospital · Not applicable, Interventional, and Diagnostic

Phase
Not applicable
Study type
Interventional
Enrollment
2,650
Allocation
Randomized
Ages
0 Years to 18 Years
Sex
All
01

Study summary

Children are sensitive to ionizing radiation, and there are significant regional variations in current pediatric CT radiation doses. Although there are studies on low-dose CT targeting single lesions, these studies require clear clinical indications and support from advanced equipment, making widespread promotion difficult. The establishment of low-dose CT protocols is mostly experience-based; when radiologists lack confidence in image quality, the credibility of diagnostic reports is compromised. Therefore, the development of low-dose protocols must meet the diagnostic confidence of most radiologists, enable clear visualization of key anatomical structures in clinical practice, and satisfy the requirements for disease diagnosis.

The purpose of this study is to establish a pediatric low-dose CT scanning protocol using Low-dose Simulation of CT (LDS) technology, and conduct a multicenter randomized controlled trial (RCT) in clinical settings to verify the clinical feasibility of this low-dose CT scanning protocol.

02

Conditions studied

  • Radiation Dose Reduction

Keywords

  • Tomography, X-ray computed
  • Child
  • radiation dose
03

In context

Lead sponsor

Beijing Children's Hospital is the lead sponsor of 51 studies on the registry; 15 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
0 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Aged 0-17 years.
  • Pediatric patients for whom a CT examination is deemed necessary by an attending physician.

Exclusion criteria

Exclusion Criteria:

  • Parents/guardians refuse to consent to low-dose CT examination.
  • Pediatric patients are in critical condition, with no time allocated for explanation of the randomized controlled trial (RCT) protocol.
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Outcomes assessor)
Enrollment
2,650 participants (estimated)

Study arms

  • No intervention
    Routine dose CT

    Participants will undergo a routine dose CT adopting China's pediatric CT Diagnostic Reference Level protocol

  • Experimental
    Low dose CT

    Participants will undergo a low dose CT adopting the pediatric low-dose CT protocol established based on LDS

    Radiation: Low dose CT

Interventions

  • RadiationLow dose CT

    Participants will undergo a low dose CT adopting the pediatric low-dose CT protocol established based on low dose simulation technique.

06

What researchers measure

Primary outcomes

  1. To evaluate the diagnostic performance of CT findings, including the concordance rate with pathological gold standards, other imaging modalities (e.g., MRI), or clinical diagnoses.

    With the clinical diagnosis (finally confirmed in pediatric patients after consultation, based on pathology, laboratory tests, other imaging examinations, and clinical characteristics) as the gold standard, determine the concordance rate between CT findings and clinical diagnoses.

    Time frame: From enrollment to the end of treatment at 12 weeks

Secondary outcomes

  1. To assess discrepancies in subjective image quality ratings among observers, using the Multi-Rater Concordance Correlation (MCRC) statistical method to evaluate the consistency of ratings across different observers.

    To analyze differences in diagnostic confidence in images among observers with different years of experience. For CT diagnostic reports showing insufficient diagnostic confidence, the specific criterion is the frequency of descriptive terms indicating low confidence (e.g., "possible," "further examination required," "follow-up review recommended") in the reports. To compare differences in radiation doses (CTDI in mSv) between two CT protocols with different dose settings. To calculate the radiation dose (CTDI in mSv) difference between the two protocols based on radiation dose data from dose reports.

    Time frame: From enrollment to the end of treatment at 12 weeks

07

Study locations

20 sites
  • Beijing Children's Hospital, Capital Medical University, National Center for Children's Health
    Beijing, Beijing Municipality, China
  • Beijing Friendship Hospital, Capital Medical University
    Beijing, Beijing Municipality, China
  • Beijing Tongren Hospital, Capital Medical University
    Beijing, Beijing Municipality, China
  • Medical Center for Capital Children's Health, Capital Medical University
    Beijing, Beijing Municipality, China
  • National Institute for Radiological Protection, China CDC
    Beijing, Beijing Municipality, China
  • Peking Union Medical College Hospital
    Beijing, Beijing Municipality, China
  • Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders.
    Chongqing, Chongqing Municipality, China
  • Guangdong Women and Children Hospital
    Guangzhou, Guangdong, China
  • Nanfang Hospital, Southern Medical University
    Guangzhou, Guangdong, China
  • Baoding Hospital, Beijing Children's Hospital Affiliated to Capital Medical University
    Baoding, Heibei, China
  • Fuwai Central China Cardiovascular Hospital
    Zhengzhou, Henan, China
  • The Third Affiliated Hospital of Zhengzhou University
    Zhengzhou, Henan, China
  • Affiliated Women's Hospital of Jiangnan University
    Wuxi, Jiangsu, China
  • Children's Hospital of Changchun
    Changchun, Jilin, China
  • the First Hospital of Jilin University
    Changchun, Jilin, China
  • The First Affiliated Hospital of Xi'an Jiao Tong University
    Xi'an, Shaanxi, China
  • Shanghai Children's Medical Center, School of Medicine
    Shanghai, Shanghai Municipality, China
  • Shanghai Jiao Tong University School of Medicine
    Shanghai, Shanghai Municipality, China
  • ShanghaiTech University
    Shanghai, Shanghai Municipality, China
  • People's Hospital of Xinjiang Uygur Autonomous Region
    Ürümqi, Xinjiang, China
08

References and documents

Publications

  • Xu H, Sun QF, Yue BR, Cheng JS, Niu YT. Results and analysis of examination doses for paediatric CT procedures based on a nationwide survey in China. Eur Radiol. 2024 Mar;34(3):1659-1666. doi: 10.1007/s00330-023-10005-7. Epub 2023 Sep 6. PubMed 37672054 ↗
  • Bosch de Basea M, Thierry-Chef I, Harbron R, Hauptmann M, Byrnes G, Bernier MO, Le Cornet L, Dabin J, Ferro G, Istad TS, Jahnen A, Lee C, Maccia C, Malchair F, Olerud H, Simon SL, Figuerola J, Peiro A, Engels H, Johansen C, Blettner M, Kaijser M, Kjaerheim K, Berrington de Gonzalez A, Journy N, Meulepas JM, Moissonnier M, Nordenskjold A, Pokora R, Ronckers C, Schuz J, Kesminiene A, Cardis E. Risk of hematological malignancies from CT radiation exposure in children, adolescents and young adults. Nat Med. 2023 Dec;29(12):3111-3119. doi: 10.1038/s41591-023-02620-0. Epub 2023 Nov 9. PubMed 37946058 ↗

Individual participant data

Plan to share: Undecided

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 30, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07199101
Lead sponsor
Beijing Children's Hospital
Responsible party
Sponsor
First posted
Sep 30, 2025
Start date
Jan 1, 2026 (estimated)
Primary completion
Dec 31, 2027 (estimated)
Completion
Dec 31, 2027 (estimated)
Last update
Sep 30, 2025

Study contacts

Jihang Sun, MD
Contact
jihangsuns@163.com
+86 13521158011

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion